BioShares Biotechnology Historical Price Analysis

BioShares Biotechnology Products -- USA Etf  

USD 41.29  0.58  1.42%

Use BioShares Biotechnology Products Historical Price Analysis together with your etf portfolios to enhance returns of your portfolios and to determine Etf optimization strategy that fits your criteria.  
 Time Horizon     30 Days    Login   to change

Performance History


Highest PriceJanuary 12, 201841.61
Lowest PricJanuary 8, 201840.3
The price series of BioShares Biotechnology for the period between Wed, Dec 20, 2017 and Fri, Jan 19, 2018 has a statistical range of 1.84 with a coefficient of variation of 1.37. The prices are distributed with arithmetic mean of 40.71. The median price for the last 30 days is 40.83
OpenHighLowCloseVolume
01/19/2018 40.8  41.3  40.8  41.29  4,235 
01/18/2018 40.68  40.82  40.68  40.71  1,195 
01/17/2018 40.43  40.65  40.3  40.65  3,725 
01/16/2018 41.61  41.7  41.19  41.19  1,623 
01/12/2018 41.29  41.66  41.25  41.61  4,440 
01/11/2018 41.15  41.15  41.05  41.08  3,555 
01/10/2018 40.43  40.84  40.43  40.77  965 
01/09/2018 40.9  41.05  40.9  40.99  1,889 
01/08/2018 41.07  41.07  40.2  40.3  8,287 
01/05/2018 41.21  41.28  41.13  41.28  2,286 
01/04/2018 41.13  41.25  40.95  41.2  4,168 
01/03/2018 41.13  41.57  41.08  41.57  4,554 
01/02/2018 40.94  41.08  40.52  41.08  2,680 
12/29/2017 41  41.11  40.56  40.56  3,097 
12/28/2017 41.18  41.18  40.81  40.98  1,919 
12/27/2017 41.03  41.03  40.86  40.86  2,304 
12/26/2017 40.67  40.86  40.59  40.83  3,288 

Did you try this?

Run Stock Tickers Now
   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Hide  View All  NextLaunch Stock Tickers

Net Asset

BioShares Biotechnology Net Asset Analysis
BioShares Biotechnology Products is rated below average in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Health category is currently estimated at about 42.35 Billion. BioShares Biotechnology adds roughly 38.48 Million in net asset claiming only tiny portion of all ETFs under Health category.